Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition

International Journal of Cancer

Volumn 67, Issue 2, 1996, Pages 283-288

  Baldwin, Rae Lynn ^a,c   Friess, Helmut ^b   Yokoyama, Munehiro ^a   Lopez, Martha E ^a   Kobrin, Michael S ^a   Büchler, Markus W ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ARTICLE; CANCER RESISTANCE; CANCER RISK; CELL ADHESION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LIGAND BINDING; PANCREAS CELL; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CELL DIVISION; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029810920     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B     Document Type: Article

References (28)

1. ANZANO, M.A., ROBERTS, A.B., DELARCO, J.E., WAKEFIELD, L.M., ASSOIAN, R.K., ROCHE, N.S., SMITH, J.M., LAZARUS, J.E. and SPORN, M.B., Increased secretion of type beta transforming growth factor accompanies viral transformation of cells. Mol. cell. Biol., 5, 242-247 (1985).
2. ARRICK, B.A., LOPEZ, A.R., ELFMAN, F., EBNER, R., DAMSKY, C.H. and DERYNCK, R., Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol., 118, 715-726 (1992).
3. ARTEAGA, C.J., CARTY-DUGGER, T., MOSES, H.L., HERD, S.D. and PIETENPOL, J.L., Transforming growth factor-β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differentiation, 4, 193-201 (1993).
4. ATTISANO, L., CARCAMO, J., VENTURA, F., WEIS, F.M.B., MASSAGUÉ, J. and WRANA, J.L., Identification of human activin and TGF-β type I receptors that form heteromeric kinase complexes with type II receptors. Cell, 75, 671-680 (1993).
5. BALDWIN, R.L. and KORC, M., Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors, 8, 23-34 (1993).
6. CHEN, R.-H., EBNER, R. and DERYNCK, R., Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science, 260, 1335-1338 (1993).
7. EBNER, R., CHEN, R.-H., SHUM, L., LAWLER, S., ZIONCHECK, T.F., LEE, A., LOPEZ, A.R. and DERYNCK, R., Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science, 260, 1344-1348 (1993).
8. FRANZEN, P., TEN DIJKE, P., ICJIJO, H., YAMASHITA, H., SCHULZ, P., HELDIN, C.H. and MIYAZONO, K., Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75, 681-692 (1993).
9. FRIESS, H., YAMANAKA, Y., BÜCHLER, M., BEGER, H.G., KOBRIN, M.S., BALDWIN, R.L. and KORC, M., Enhanced expression of the type II transforming growth factor-beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res., 53, 2704-2707 (1993a).
10. FRIESS, H., YAMANAKA, Y., BÜCHLER, M., EBERT, M., BEGER, H.G., GOLD, L.I. and KORC, M., Enhanced expression of transforming growth factor-β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology, 105, 1846-1856 (1993b).
11. GOMELLA, L.G., SARGENT, E.R., WADE, T.P., ANGLARD, P., LINEHAN, W.M. and KASID, A., Expression of transforming growth factor α in normal human adult kidney and enhanced expression of transforming growth factors α and -β1 in renal cell carcinoma. Cancer Res., 49, 6972-6975 (1989).
12. GORSCH, S.M., MEMOLI, V.A., STUKEL, T.A., GOLD, L.I. and ARRICK, B.A., Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer. Cancer Res., 52, 6949-6952 (1992).
13. HERMANEK, P. and SOBIN, L.H., UICC: TNM classification of malignant tumors, pp. 65-68, Springer, New York (1987).
14. ITO, N., KAWATA, S., TAMURA, S., TAKAISHI, K., SHIRAI, Y., KISO, S., YABUUCHI, I., MATSUDA, Y., NISHIOKA, M. and TARUI, S., Elevated levels of transforming growth factor 1 messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res., 51, 4080-4083 (1991).
15. JENNINGS, M.T., MACIUNAS, R.J., CARVER, R., BASCOM, C.C., JUNEAU, P., MISULIS, K. and MOSES, H.L., TGF-β1 and TGF-β2 are potent growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int. J. Cancer, 49, 129-139 (1991).
16. KADIN, M.E., CAVAILLE-COLL, M.W., GERTZ, R., MASSAGUÉ J., CHEIFETZ, S. and GEORGE, D., Loss of receptors for transforming growth factor β in human T cell malignancies. Proc. nat. Acad. Sci. (Wash.), 91, 6002-6006 (1994).
17. LAIHO, M., DECAPRIO, J.A., LUDLOW, J.W., LIVINGSTON, D.M. and MASSAGUÉ, J., Growth inhibition by TGF-βs linked to suppression of retinoblastoma protein phosphorylation. Cell, 62, 175-185 (1990).
18. LIN, H.Y., WANG, X.-F., NG-EATON, E., WEINBERG, R.A. and LODISH, H.F., Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68, 775-785 (1992).
19. LOPEZ-CASILLAS, F., WRANA, J.L. and MASSAGUÉ, J., Betaglycan presents ligand to the TGF-β signaling receptor. Cell, 73, 1435-1444 (1993).
20. MARKOWITZ, S., WANG, J., MEYEROFF, L., PARSONS, R., SUN, L., LUTTERBAUGH, J., FAN, R.S., ZBOROWSKA, E., KINZLER, K.W., VOGELSTEIN, B., BRATTAIN, M. and WILSON, J.K.V., Inactivation of the TGF-β type II receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
21. MATSUZAKI, K., XU, J., SANG, F., MCKEEHAN, W.L., KRUMMEN, L. and KAN, M., A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor-β, or bone morphogenic factor. J. biol. Chem., 268, 12719-12723 (1993).
22. MOREN, A., ICHIJO, H., and MIYAZONO, K., Molecular cloning and characterization of the human and porcine transforming growth factor-beta type III receptors. Biochem. biophys. Res. Comm., 189, 356-362 (1992).
23. PARK, K., KIM, S-J., BANG, Y-J., PARK, J-G., KIM, N.K., ROBERTS, A.B. and SPORN, M.B., Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. not. Acad. Sci. (Wash.), 91, 8772-8776 (1994).
24. SPORN, M.B. and ROBERTS, A.B., Transforming growth factor-β: recent progress and new challenges. J. Cell Biol., 119, 1017-1021 (1992).
25. STEINER, M.S. and BARRACK, E.R., Transforming growth factor-β overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6, 15-25, (1992).
26. TEN DIJKE, P., YAMASHITA, H., ICJIJO, H., FRANZÉN, P., LAIHO, M., MIYAZONO, K. and HELDIN, C.H., Characterization of type I receptors for transforming growth factor beta and activin. Science, 264, 101-104 (1994).
27. WRANA, J.L., ATTISANO, L., WEISER, L., VENTURA, F. and MASSAGUÉ, J., Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370, 341-347 (1994).
28. WYLLIE, F.S., DAWSON, T., BOND, J.A., GORETZKI, P., GAME, S., PRIME, S. and WYNFORD-THOMAS, D., Correlated abnormalities of transforming growth factor-β response and p53 expression in thyroid epithelial cell transformation. Mol. cell. Endocrinol, 76, 13-21 (1991).